Yellow Fever

2021 ◽  
Author(s):  
Melvin Sanicas ◽  
Merlin Sanicas

Yellow fever is an acute viral hemorrhagic disease transmitted by infected mosquitoes. The "yellow" in the name refers to the jaundice from direct liver damage. The virus is endemic in tropical areas of Africa and Central and South America. There is no specific treatment or antiviral drug for yellow fever but appropriate supportive treatment in hospitals improves survival rates. Vaccination is the single most important preventive measure. Several yellow fever vaccines are manufactured by different developers. All of them are safe, affordable, and appear to provide protection for >30–35 years. Some are WHO-prequalified. The Eliminate Yellow Fever Epidemics (EYE) Strategy launched in 2017 aims at protecting at-risk populations, preventing international spread, and containing outbreaks rapidly. By 2026, it is expected that more than 1 billion people will be protected against the disease.

2018 ◽  
Vol 97 (4) ◽  
pp. 407-414
Author(s):  
Marcelo Augusto Fontanelle Ribeiro Junior ◽  
Vinicius Cunha Rodrigues ◽  
Celia Ya Dan Feng ◽  
Alexander Trong Minh Nguyen ◽  
Giovana El Khouri Bechara ◽  
...  

Since January 2017, there have been at least 1563 suspected cases of Yellow Fever, 629 confirmed cases and 232 confirmed deaths. Yellow fever is a viral hemorrhagic disease endemic to the tropical parts of Africa and South America. At the present time, it has presented a significant increase in its incidence in Brazil, with important repercussions and impacts on the public health. This review paper outlines the causes of yellow fever, as well as the disease epidemiology, progression, diagnosis, treatment and prevention. We conclude by reporting on the current epidemic in Brazil and future directions for research. Method: Data from Pubmed, SciELO, Medline and government sources concerning Yellow Fever were used, dating from 2002 to 2018. In the collection of the data the following descriptors were used: Yellow-fever, Aedes, Arbovirus and Flavivirus.


2020 ◽  
Vol 11 (SPL1) ◽  
pp. 475-481
Author(s):  
Jotheeswari P ◽  
Yuvaraj M ◽  
Balaji K ◽  
Gunapriya Raghunath ◽  
Kumaresan M

COVID-19 is a current sensational and dangerous threat that affects millions of people across the world. As the day progresses the rate of growth of COVID-19 drastically increases. No vaccine or specific antiviral drug are active against corona, therefore, preventing the exposure to the virus is the base of support against its spread across the world. Despite the implementation of preventive measures, the rate of virus-infected cases progressively increases which stimulates our thought process to raise a question, whether the preventive measures that we follow are effective against the spread of COVID-19 infection. Evidence from previous literature obtained from various online tools implies multiple preventive measures that should be followed and also illustrates their mechanism of action against the active spread of COVID-19 infection. According to the results from the evidence, we can identify the gold standard preventive measure among the described preventive measures. The precautionary measure encompasses both pharmaceutical interventions and non- pharmaceutical interventions among which non-pharmaceutical measures are superior in the prevention of the developing pandemic. Among the non-pharmaceutical interventions, social distancing is the paramount to other measures in the mitigation of the spread of viral infection.


2021 ◽  
Vol 13 (11) ◽  
pp. 2231
Author(s):  
Débora Souza Alvim ◽  
Júlio Barboza Chiquetto ◽  
Monica Tais Siqueira D’Amelio ◽  
Bushra Khalid ◽  
Dirceu Luis Herdies ◽  
...  

The scope of this work was to evaluate simulated carbon monoxide (CO) and aerosol optical depth (AOD) from the CAM-chem model against observed satellite data and additionally explore the empirical relationship of CO, AOD and fire radiative power (FRP). The simulated seasonal global concentrations of CO and AOD were compared, respectively, with the Measurements of Pollution in the Troposphere (MOPITT) and the Moderate-Resolution Imaging Spectroradiometer (MODIS) satellite products for the period 2010–2014. The CAM-chem simulations were performed with two configurations: (A) tropospheric-only; and (B) tropospheric with stratospheric chemistry. Our results show that the spatial and seasonal distributions of CO and AOD were reasonably reproduced in both model configurations, except over central China, central Africa and equatorial regions of the Atlantic and Western Pacific, where CO was overestimated by 10–50 ppb. In configuration B, the positive CO bias was significantly reduced due to the inclusion of dry deposition, which was not present in the model configuration A. There was greater CO loss due to the chemical reactions, and shorter lifetime of the species with stratospheric chemistry. In summary, the model has difficulty in capturing the exact location of the maxima of the seasonal AOD distributions in both configurations. The AOD was overestimated by 0.1 to 0.25 over desert regions of Africa, the Middle East and Asia in both configurations, but the positive bias was even higher in the version with added stratospheric chemistry. By contrast, the AOD was underestimated over regions associated with anthropogenic activity, such as eastern China and northern India. Concerning the correlations between CO, AOD and FRP, high CO is found during March–April–May (MAM) in the Northern Hemisphere, mainly in China. In the Southern Hemisphere, high CO, AOD, and FRP values were found during August–September–October (ASO) due to fires, mostly in South America and South Africa. In South America, high AOD levels were observed over subtropical Brazil, Paraguay and Bolivia. Sparsely urbanized regions showed higher correlations between CO and FRP (0.7–0.9), particularly in tropical areas, such as the western Amazon region. There was a high correlation between CO and aerosols from biomass burning at the transition between the forest and savanna environments over eastern and central Africa. It was also possible to observe the transport of these pollutants from the African continent to the Brazilian coast. High correlations between CO and AOD were found over southeastern Asian countries, and correlations between FRP and AOD (0.5–0.8) were found over higher latitude regions such as Canada and Siberia as well as in tropical areas. Higher correlations between CO and FRP are observed in Savanna and Tropical forests (South America, Central America, Africa, Australia, and Southeast Asia) than FRP x AOD. In contrast, boreal forests in Russia, particularly in Siberia, show a higher FRP x AOD correlation than FRP x CO. In tropical forests, CO production is likely favored over aerosol, while in temperate forests, aerosol production is more than CO compared to tropical forests. On the east coast of the United States, the eastern border of the USA with Canada, eastern China, on the border between China, Russia, and Mongolia, and the border between North India and China, there is a high correlation of CO x AOD and a low correlation between FRP with both CO and AOD. Therefore, such emissions in these regions are not generated by forest fires but by industries and vehicular emissions since these are densely populated regions.


2018 ◽  
Vol 64 (6) ◽  
pp. 498-500 ◽  
Author(s):  
Michelle Larissa Zini Lise ◽  
Michael Laurence Zini Lise

SUMMARY The Yellow Fever virus was isolated in 1927 and the disease is considered endemic and epidemic in tropical regions of South America and Africa, with thousands of new cases reported annually. Several side effects of the vaccine have already been reported. Although reports of skin rash secondary to the vaccine range from 0 to 15%, no image or detailed description of the lesions were found in the literature. Here we describe a rash on a toddler vaccinated to travel.


KYAMC Journal ◽  
2017 ◽  
Vol 7 (1) ◽  
pp. 719-725
Author(s):  
Md Daharul Islam ◽  
SM Tajdit Rahman ◽  
Khaleda Akhter ◽  
Md Azizul Hoque ◽  
Anannya Roy ◽  
...  

Zika virus is a flavivirus related to Dengue virus, yellow fever virus and West Nile virus. It is considered an emerging arbovirus transmitted by mosquito of the genus Aedes. Its first description took place in 1947 in the Zika Forest in Uganda, isolated on Rhesus monkey used as bait to study the yellow fever virus. Clinical picture is characterized as a 'dengue-like' syndrome, with abrupt onset of fever; and an early onset of evanescent rash, often pruritic. Occasionally the disease has been associated with Guillain-Barré syndrome. The diagnosis can be performed by PCR or by IgG and IgM antibodies detection. No specific treatment or vaccine is available for Zika virus disease. Treatment is generally supportive. Control measures are same for dengue and chikungunya based mostly on health education and vector control.KYAMC Journal Vol. 7, No.-1, Jul 2016, Page 719-725


2018 ◽  
Author(s):  
André C. Ferreira ◽  
Patrícia A. Reis ◽  
Caroline S. de Freitas ◽  
Carolina Q. Sacramento ◽  
Lucas Villas Bôas Hoelz ◽  
...  

AbstractChikungunya virus (CHIKV) causes a febrile disease associated with chronic arthralgia, which may progress to neurological impairment. Chikungunya fever (CF) is a consolidated public health problem, in tropical and subtropical regions of the world, where control of CHIKV vector, mosquitos of theAedesgenus, failed. Since there is no vaccine or specific treatment against CHIKV, infected patients receive only palliative care to alleviate pain and arthralgia. Thus, drug repurposing is necessary to identify antivirals against CHIKV. Recently, the structure and activity of CHIKV RNA polymerase was partially resolved, revealing similar aspects with the enzyme counterparner on other positive sense RNA viruses, such as members of the Flaviviridae family. We then evaluated if sofosbuvir, clinically approved against hepatitis C virus RNA polymerase, which also aims to dengue, Zika and yellow fever viruses replication, would inhibit CHIKV replication. Indeed, sofosbuvir was 5-times more selective in inhibiting CHIKV production in human hepatoma cells than ribavirin, a pan-antiviral drug. Although CHIKV replication in human induced pluripotent stem cell (iPS)-derived astrocytes was less sensitive to sofosbuvir’s, compared to hepatoma cells – this drug still impaired virus production and cell death in a MOI-dependent manner. Sofosbuvir also exhibited antiviral activityin vivo, by preventing CHIKV-induced paw oedeme in adult mice, at 20 mg/kg/day, and mortality on neonate mice model, at 40 and 80 mg/kg/day. Our data demonstrates that a prototypic alphavirus, CHIKV, is also susceptible to sofosbuvir. Since this is a clinically approved drug, it could pave the way to become a therapeutic option against CF.


2021 ◽  
Vol 15 (6) ◽  
pp. e0009417
Author(s):  
Christin H. Goodman ◽  
Maurice Demanou ◽  
Mick Mulders ◽  
Jairo Mendez-Rico ◽  
Alison Jane Basile

Yellow fever (YF), an arboviral disease, affects an estimated 200,000 people and causes 30,000 deaths per year and recently has caused major epidemics in Africa and South America. Timely and accurate diagnosis of YF is critical for managing outbreaks and implementing vaccination campaigns. A YF immunoglobulin M (IgM) antibody-capture (MAC) enzyme-linked immunosorbent assay (ELISA) kit, the YF MAC-HD, was successfully introduced starting in 2018 to laboratories in Africa and South America. The YF MAC-HD kit can be performed in 3.5 hours, test up to 24 samples, and includes all reagents necessary to perform the test, except for water used to dilute wash buffer. In 2018 and 2019, a total of 56 laboratory personnel from 39 countries in Africa and South America were trained to use the kit during workshops, followed by take-home YF IgM proficiency testing (PT) exercises. Participants received either a 10- or 20-sample YF PT panel and performed testing using the YF MAC-HD kit. All countries obtained 90% or higher correct results. These results verified the technical viability and transferability of YF MAC-HD kit use for laboratories in YF-endemic countries.


2019 ◽  
Vol 97 (Supplement_3) ◽  
pp. 32-33
Author(s):  
Jose Luiz Moraes Vasconcelos ◽  
Reinaldo F Cooke ◽  
Mauro Meneghetti ◽  
Isaias Claro Junior ◽  
Rogerio Peres ◽  
...  

Abstract The majority of beef cow herds in South America are constituted by Bos indicus females, which have particular reproductive features that contribute to reduced reproductive efficiency compared with that of B. taurus cohorts. B. indicus heifers reach puberty at an older age compared with B. taurus heifers. Nutritional challenges are critical in cows maintained on low-quality tropical pastures, given that nutrient intake during the postpartum period is not sufficient to meet their requirements for growth and lactation. Several alternatives to enhance reproductive efficiency of B. indicus heifers and cows have been developed to address their inherent reproductive shortcomings. These research-based technologies include: a) hormonal protocols to induce puberty in nulliparous heifers, b) hormonal protocols to synchronize estrus and/or ovulation in B. indicus females to exploit their reproductive responses to artificial insemination, and c) genetic and environmental factors that influence reproductive success in beef herds, including reproductive diseases and excitable temperament of B. indicus females, which have been investigated to support/promote the development of appropriate mitigation technologies. The objective of this presentation is to discuss pharmacological and management technologies to improve reproductive performance of cow-calf systems from tropical areas in South America. Currently, there are hormonal treatments allowing South American B. indicus producers to reach the benchmark of 50% pregnancy rate to TAI, as well as enhance the percentage of cows becoming pregnant to AI at the beginning of the breeding season. This outcome is expected to optimize use of labor, and increase calf weaning age and weight via genetic improvement and concentration of births at the beginning of the calving season.


2006 ◽  
Vol 41 (2) ◽  
pp. 117-122 ◽  
Author(s):  
Nicolas Degallier ◽  
Hamilton A. De Oliveira Monteiro ◽  
Francisco C. Castro ◽  
Orlando V. Da Silva ◽  
Gregório C. SÁ. Filho ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document